Healthcare stocks were steady premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) inactive.

Hims & Hers Health (HIMS) stock was up more than 3% after the company said it has completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.